What is Bio-Techne's additional paid-in capital?

Bio-Techne (TECH) reported additional paid-in capital of $1.01B in Q1 2026.

How has Bio-Techne's additional paid-in capital changed year-over-year?

Bio-Techne's additional paid-in capital increased by 11.4% year-over-year, from $902.12M to $1.01B.

What is the long-term trend for Bio-Techne's additional paid-in capital?

Over 4 years (2021 to 2025), Bio-Techne's additional paid-in capital has grown at a 14.3% compound annual growth rate (CAGR), from $534.41M to $911.09M.

Bio-Techne TECH Additional Paid-In Capital

Additional Paid-In Capital at other companies

Thermo Fisher ScientificTMO

——

DanaherDHR

——

RevvityRVTY

——

Charles River LaboratoriesCRL

——

WAT

Waters CorporationWAT

——

Tempus AI, Inc.TEM

——

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Techne's additional paid-in capital?: Bio-Techne (TECH) reported additional paid-in capital of $1.01B in Q1 2026.
How has Bio-Techne's additional paid-in capital changed year-over-year?: Bio-Techne's additional paid-in capital increased by 11.4% year-over-year, from $902.12M to $1.01B.
What is the long-term trend for Bio-Techne's additional paid-in capital?: Over 4 years (2021 to 2025), Bio-Techne's additional paid-in capital has grown at a 14.3% compound annual growth rate (CAGR), from $534.41M to $911.09M.